+++ Ihre Meinung ist uns wichtig: Wie zufrieden sind Sie mit finanzen.ch? - Hier an unserer Umfrage teilnehmen! +++ -w-
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
14.10.2019 00:36:00

Marijuana Stock Tilray Is Ramping Up Its CBD Partnership With Anheuser-Busch InBev

Tilray (NASDAQ: TLRY) and Anheuser-Busch InBev (NYSE: BUD) are taking their partnership to the next level. The cannabis maker and brewing king will work together to produce and market nonalcoholic beverages containing cannabidiol (CBD). The CBD-infused drinks will go on sale in Canada once regulations allow, and potentially as early as December.CBD is a nonpsychoactive component of the cannabis plant. Unlike tetrahydrocannabinol, the psychoactive component of marijuana, CBD doesn't get people high. But thanks to its perceived health benefits, CBD is becoming increasingly popular. Analysts at market research company Brightfield Group forecast the CBD market to grow to nearly $24 billion by 2023, up from approximately $620 million in 2018.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

Nachrichten zu Anheuser-Busch InBev SA (spons. ADRs)mehr Nachrichten

Analysen zu Anheuser-Busch InBev SA (spons. ADRs)mehr Analysen

27.08.19 Anheuser-Busch InBev Underweight Barclays Capital

Eintrag hinzufügen

Neue Woche – neue Hochs? | BX Swiss TV

Aktien in diesem Artikel

Finanzen.net News

pagehit